| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PLoSO..1027515D |
| P356 | DOI | 10.1371/JOURNAL.PONE.0127515 |
| P932 | PMC publication ID | 4444272 |
| P698 | PubMed publication ID | 26010093 |
| P5875 | ResearchGate publication ID | 277881633 |
| P50 | author | Tadeu Uggere Andrade | Q55318687 |
| Rogerio F Ribeiro | Q82255268 | ||
| Adriana K Carmona | Q92072817 | ||
| P2093 | author name string | A Z Lamas | |
| N S Bissoli | |||
| S A Gouvea | |||
| G R Abreu | |||
| M R Moyses | |||
| M F Alves | |||
| I F Caliman | |||
| P L M Dalpiaz | |||
| P2860 | cites work | Hypertension: what's sex got to do with it? | Q26866656 |
| Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase | Q28115041 | ||
| Angiotensin-converting enzyme 2 is an essential regulator of heart function | Q28205840 | ||
| Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats | Q28319565 | ||
| Gender differences in hypertension in spontaneously hypertensive rats: role of androgens and androgen receptor | Q28374406 | ||
| Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression | Q28583180 | ||
| Phospholamban: protein structure, mechanism of action, and role in cardiac function | Q30431816 | ||
| Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases | Q33677369 | ||
| Gender differences in the regulation of blood pressure | Q33947308 | ||
| Soybean oil increases SERCA2a expression and left ventricular contractility in rats without change in arterial blood pressure | Q33951980 | ||
| Sex hormones as potential modulators of vascular function in hypertension | Q34074830 | ||
| Recent advances involving the renin-angiotensin system | Q34260674 | ||
| Androgen regulation of rat renal angiotensinogen messenger RNA expression | Q34574911 | ||
| Blood pressure and mesenteric vascular reactivity in spontaneously hypertensive rats 7 months after gonadectomy | Q34815888 | ||
| Vasopeptidase inhibition: a double-edged sword? | Q35080519 | ||
| Angiotensin (1-7) receptor antagonism equalizes angiotensin II-induced hypertension in male and female spontaneously hypertensive rats | Q35093093 | ||
| Pharmacological modulation of cardiovascular remodeling: a guide to heart failure therapy | Q35584025 | ||
| ACE2, a new regulator of the renin-angiotensin system | Q35756519 | ||
| Strategies and methods for research on sex differences in brain and behavior | Q35993249 | ||
| Sexual dimorphism in rodent models of hypertension and atherosclerosis | Q36346910 | ||
| Sex differences in circulating and renal angiotensins of hypertensive mRen(2). Lewis but not normotensive Lewis rats | Q36807861 | ||
| Sex differences in angiotensin-converting enzyme modulation of Ang (1-7) levels in normotensive WKY rats | Q36853835 | ||
| Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition | Q37089449 | ||
| The role of oxidative stress and lipid peroxidation in ventricular remodeling induced by tobacco smoke exposure after myocardial infarction. | Q37261274 | ||
| Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy | Q50502374 | ||
| Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats | Q50910155 | ||
| Angiotensin II type 2 receptor gene transfer elicits cardioprotective effects in an angiotensin II infusion rat model of hypertension. | Q51611884 | ||
| Use of tibial length to quantify cardiac hypertrophy: application in the aging rat. | Q52434004 | ||
| Role of angiotensin II type 2 receptor during regression of cardiac hypertrophy in spontaneously hypertensive rats. | Q53120561 | ||
| Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure - A population study | Q58666697 | ||
| Modulation of blood pressure and the renin-angiotensin system in transgenic and spontaneously hypertensive rats afer ovariectomy | Q72364410 | ||
| Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system | Q73371712 | ||
| The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility | Q73457987 | ||
| Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS | Q74065824 | ||
| Na(+)influx via Na(+)/H(+)exchange activates protein kinase C isozymes delta and epsilon in cultured neonatal rat cardiac myocytes | Q78050105 | ||
| Local RAS and inflammatory factors are involved in cardiovascular hypertrophy in spontaneously hypertensive rats | Q81666701 | ||
| ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction | Q84314698 | ||
| Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. | Q37281123 | ||
| Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice | Q37350650 | ||
| The chronic blockade of angiotensin I-converting enzyme eliminates the sex differences of serum cytokine levels of spontaneously hypertensive rats. | Q37371365 | ||
| Sex-related differences in myocardial remodeling. | Q37707569 | ||
| Gender and the renin-angiotensin-aldosterone system | Q37770594 | ||
| Anti-Hypertensive Drugs Have Different Effects on Ventricular Hypertrophy Regression | Q37776417 | ||
| Sex differences in hypertension: contribution of the renin-angiotensin system | Q38026265 | ||
| The "his and hers" of the renin-angiotensin system | Q38062455 | ||
| Gender differences in sarcoplasmic reticulum calcium loading after isoproterenol | Q42446779 | ||
| A new piece in the hypertension puzzle: central blood pressure regulation by sex steroids | Q42660396 | ||
| Ovariectomy does not affect the cardiac sympathovagal balance of female SHR but estradiol does | Q42859547 | ||
| Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction | Q43266255 | ||
| 17beta-Estradiol modulates local cardiac renin-angiotensin system to prevent cardiac remodeling in the DOCA-salt model of hypertension in rats. | Q43277846 | ||
| Gonadal effects on plasma ACE activity in mice | Q43889869 | ||
| Characterization of cardiac hypertrophy and heart failure due to volume overload in the rat. | Q44280991 | ||
| Estrogen or the AT1 antagonist olmesartan reverses the development of profound hypertension in the congenic mRen2. Lewis rat. | Q44521138 | ||
| Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice | Q44760479 | ||
| Sex differences in the development of angiotensin II-induced hypertension in conscious mice | Q45207394 | ||
| Myocardial infarction increases ACE2 expression in rat and humans. | Q45238600 | ||
| Stimulation of cardiac apoptosis in ovariectomized hypertensive rats: potential role of the renin-angiotensin system. | Q45953342 | ||
| Sex differences in expression of calcium-handling proteins and beta-adrenergic receptors in rat heart ventricle | Q46406161 | ||
| A continuous fluorescent assay for the determination of plasma and tissue angiotensin I-converting enzyme activity. | Q46525732 | ||
| The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats | Q46540535 | ||
| Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes | Q46715078 | ||
| Angiotensin-converting enzyme 2 (ACE2) and ACE activities display tissue-specific sensitivity to undernutrition-programmed hypertension in the adult rat. | Q46735122 | ||
| Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study | Q46765330 | ||
| Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology | Q46771630 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0127515 | |
| P577 | publication date | 2015-05-26 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Sex Hormones Promote Opposite Effects on ACE and ACE2 Activity, Hypertrophy and Cardiac Contractility in Spontaneously Hypertensive Rats | |
| P478 | volume | 10 |
| Q94930122 | Androgen sensitivity gateway to COVID-19 disease severity |
| Q106638260 | COVID-19 Disease Map, a computational knowledge repository of SARS-CoV-2 virus-host interaction mechanisms |
| Q99637359 | COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations |
| Q42336195 | Correction: Sex Hormones Promote Opposite Effects on ACE and ACE2 Activity, Hypertrophy and Cardiac Contractility in Spontaneously Hypertensive Rats |
| Q95828245 | Impact of sex and gender on COVID-19 outcomes in Europe |
| Q98774280 | Is Sex a Determinant of COVID-19 Infection? Truth or Myth? |
| Q97568408 | Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic |
| Q99612915 | SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors |
| Q38924269 | Sex differences in obesity-induced hypertension and vascular dysfunction: a protective role for estrogen in adipose tissue inflammation? |
| Q94476163 | The Dermatologist's Perspective: Why is COVID-19 mortality lower in females than males? |
Search more.